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          The floating drug delivery system or hydro 
dynamically balanced systems are among the several 
approaches that have been made developed in order to 
increase the gastric transit time of drug. The microspheres 
are characteristically free flowing powders consisting of 
natural or synthetic polymers and ideally having a particle 
size less than 200m. Microspheres incorporating a drug 
dispersed or dissolved throughout particle matrix have the 
potential for the controlled release of drug
1 
         Microspheres are one of the multiparticulate delivery 
system and are prepared to obtain controlled the drug release 
from the dosage form to improve bioavailability, reduces the 
adverse action and prolong the action of drug, reduce 
absorption difference in patients, reduce the dosing 
frequency and adverse effects during prolong treatment. It is 
needed to formulate in long acting dosage form, reaching to 
effective biological site rapidly.
2 
          Omeprazole   is  usually  administered  as  
conventional  tablet  form   with  the  dose  15 mg. 
omeprazole  is  proton   pump  inhibitor  which  prevents  
stomach  from  producing  gastric acid. The biological half 
life of Omeprazole is 1 to1.2hr.  
The Proton pump inhibitor drugs are used in the 
treatment when there is more acid secretion in the stomach. 
These drugs will bind to the H+/K+ ATPase present in the 
parietal cells in stomach. So to show their maximum action 
these drugs should remain in the stomach, which is possible 
by preparing the Floating Microspheres of Proton pump 
inhibitor drugs. 
       The proton pump inhibitors are well absorbed in the 
stomach at pH 5 than in intestine. The floating microspheres 
are helpful in increasing the absorption of these drugs. 
MATERIALS AND METHODS 
Omeprazole was obtained as gift sample from 
Nishka labs, Hyderabad. Ethyl cellulose, HPMC, 
Dichloromethane, Poly vinyl alcohol, Polyethylene glycol 
was obtained fromS.D Fine Chemicals Pvt Ltd Mumbai. 
Eudragit RS100 was obtained from Edict pharmaceuticals, 
Chennai. 
Preparation of Omeprazole Microspheres 
The microspheres were prepared by solvent evaporation 
method.0.46g of polyvinyl alcohol is dissolved in 100ml of 
distilled water. Different quantities of Ethyl cellulose, 
HPMC and Eudragit RS100 in individual and combination 
of these polymers was dissolved in dichloromethane by 
using magnetic stirrer. A known quantity of Omeprazole 
(40mg) was dissolved in the above polymeric solution along 
with 0.1% of polyethylene glycol (surfactant). The resulting 
solution was then poured into 500ml beaker, containing 
150ml of polyvinyl alcohol (0.46%w/v). The mechanical 
stirrer was used to evaporate dichloromethane completely by 
stirring at 700rpm for 2hrs.The details of formulation was 
mentioned in table no.1. 
ABSTRACT 
In this present study attempt was made to prepare the floating microspheres of Omeprazol which will help in releasing the 
proton pump inhibitor drugs in stomach. So that they can be absorbed in stomach for a longer period of time and show better 
bioavailability. The IR spectrum of pure drug and drug mixture indicated that there was no interaction between polymers and 
drug. The DSC also revealed that there was no interaction between polymers and drug. The shape of microspheres was almost 
spherical and smooth as indicated by SEM. Encapsulation efficiency was in the range of 66.23±0.115 to 88.53±0.578%. As the 
polymer concentration increases, the encapsulation efficiency also increases. In vitro buoyancy studies of the prepared 
microspheres was in the range of 70.9 to 79.1%.Omeprazole release from microspheres was slow and extended period of time 
due to increase in polymer concentration. The release mechanisms for all the formulation followed by non-fickian diffusion 
mechanism. The drug release from formulation OMP6 showed 87.26% for a long period of 12hrs and also observed that 
increase in Eudragit S100 concentration the drug release was decreased. The release mechanisms for all the formulation 
followed by non-fickian diffusion mechanism. 
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1 OMP1 40 0.8 0.2 0.1 20 150 900 
2 OMP 2 40 0.8 0.1 0.2 20 150 900 
3 OMP 3 40 0.8 0.1 - 20 150 900 
4 OMP 4 40 0.8 - 0.1 20 150 900 
5 OMP 5 40 0.8 0.2 - 20 150 900 
6 OMP 6 40 0.8 - 0.2 20 150 900 
7 OMP 7 40 0.8 0.1 0.1 20 150 900 
8 OMP 8 40 0.6 0.2 0.2 20 150 900 
HPMC: Hydroxy Propyl Methyl Cellulose, DCM: Dichloromethane, PVA: Polyvinyl 
As the solvent was being evaporated, the emulsifier 
continued to maintain the oil droplets in their spherical 
configuration and prevented from aggregating until the 
solvent was completely evaporated, and the microspheres 
were hardened as discrete particles. Then the microspheres 
were filtered and washed three times with distilled water, 
filtered and dried in hot air oven. Then obtained 
Omeprazole microspheres were performed for further 
studies. 
EVALUATION OF OMEPRAZOLE 
MICROSPHERES 
Bulk density and tapped density 
Bulk density and tapped density were measured 
by using 10ml graduated cylinder. The sample poured in 
the cylinder was tapped mechanically for 100 times, then 




 Each experiment for micromeritic properties was 
performed in triplicate manner. 
Bulk density = Mass / Volume 
Tapped density = Mass / Tapped volume 
Carr’s index: 
  Compressibility index is an important measure 
that can be obtained from the bulk and tapped densities. 
According to the theory, the less compressible material is 
more flow able. A material having values less than 20 to 
30% is defined as the free flowing material, based on the 
apparent bulk density and tapped density, the percentage 
compressibility of the bulk drug was determined by using 
the following formula.   It is expressed in percentage and is 
expressed by 
I = Dt - Db / Dt x 100 
Where, Dt is the tapped density of the powder and Db is 
the bulk density of the powder. 
Hausner’s ratio 
It indicates the flow properties of the powder and 
the ratio of Tapped density to bulk density of the powder 
or granules is called Hausner”s ratio.It is expressed in 
percentage and is expressed by H= Dt / Db 
Where, Dt is the tapped density of the powder and Db is 
the bulk density of the powder. 
Angle of repose: 
 Angle of repose of different formulations was 
measured by fixed funnel standing method. Microspheres 
were weighed and passed through the funnel, which was 
kept at a certain height from horizontal surface. The passed 
microspheres formed a pile of height „h‟ above the 
horizontal surface and the pile was measured
3
. The angle 
of repose was determined by   
Angle of repose  (θ) = Tan-1 ( h / r)  
Where h is the height of pile and r is radius 
Percentage yield: 
` Dried microspheres were accurately weighed and 
the percentage yield
4 
was calculated by  
% yield = (Practical yield/Theoretical yield) × 100 
Study of shape and surface morphology: 
Scanning electron microscopy was used to 
determine shape, surface topography, texture and examine 
the morphology of fractured or sectioned surface. SEM is 
commonly used method for characterizing drug delivery 
systems, owing in large part to simplicity of sample 
preparation and ease of operation. 
Particle Size analysis  
Size distribution of the microspheres was 
determined using the particle size analyzer (Microtrac) 
equipped with dry accessory system
4
. 
Drug content and entrapment efficiency 
Accurately weighed 100mg of microspheres were 
powdered in a motar and suspended in 100ml of phosphate 
buffer pH-6.8 and kept in sonication for 2hrs. Then the 
samples were centrifuged at 1000rpm for 20mins to 
remove any the supernatant layer was removed and 
filtered
43
. From this filtered solution 1ml of sample was 
withdrawn and diluted to 25ml of phosphate buffer pH-6.8 
then it was analyzed spectrophotometrically at 300nm
5
. 
i) Drug content: 
Theoretical drug content 
= (Weight of drug loaded / Total weight of Microspheres) X 100 
 
Practical drug content 
= Concentration X dilution factor X Conversion factor 
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ii) Encapsulation efficiency =  
(Actual drug content / Theoretical drug content) X 100 
In vitro buoyancy studies 
6, 7
: 
The microspheres weighing about 0.3 g were 
spread over the surface of USP XXIII dissolution 
apparatus (type II) which was filled with 900 ml of SGF 
(pH 1.2) containing 0.02% tween 20. The medium was 
agitated with a paddle rotating at 100 rpm for 12 hours. 
The floating and settled portions of microspheres were 
recovered separately and were dried and weighed. 
Buoyancy percentage was calculated by using formula:           
                             Weight of floating microspheres   
% Buoyancy=  ------------------------------------------- X 100                    
   Initial weight of microspheres 
In-vitro dissolution studies 
 In-vitro dissolution studies of Omeprazole loaded 
microspheres were performed using USP Paddle Type 
dissolution test apparatus.100mg of drug loaded 
microspheres were placed in a muslin cloth and tied to the 
paddle. 900ml of buffer is used as a dissolution medium. 




The in vitro dissolution studies were performed at 
two different pH values i.e. pH 
1.2 (simulated gastric fluid pH) for 2 hrs and pH 6.8 
(simulated intestinal fluid pH) for 12 hrs. An accurately 
weighed sample was responded in dissolution medium 
consisting 900ml of buffer and dissolution was done up to 
12hrs.At prefixed time intervals (every 1hour); 1ml of 
sample was withdrawn and filtered through 0.4 μm 
membrane filter. The volume of the dissolution medium 
was adjusted to 900ml at every sampling time by replace 
same 1ml of dissolution medium
4
. Then the samples were 
analyzed spectrophotometrically at 300nm. 
The release data obtained were fitted into various 
mathematical models like zero order, Higuchi and 
Korsmeyer-Peppas to know which mathematical model 
was best fitting the obtained release profile. 
RESULT AND DISCUSSION 
 PREFORMULATION STUDIES: 
Solubility analysis 
The available literature on solubility profile of 
Omeprazole indicated that the drug is Very slightly soluble 
in water, soluble in methylene chloride, sparingly soluble 
in ethanol (96 per cent) and in methanol. It dissolves in 
dilute solutions of alkali hydroxides. 
Omeprazole was found to be freely soluble in 
dichloromethane and Methylene hydrochloride, slightly 
soluble in ethanol, acetone and methanol, practically 
insoluble in water. The study was carried out to select 
suitable dissolution medium for in-vitro release studies. 
The solubility of Omeprazole in acid buffer of pH 1.2 was 
highest. Hence media containing acid buffer of pH 1.2 
were selected for dissolution studies. 
 
FT-IR spectral analysis 
The development of a successful formulation 
depends only on suitable selection of excipients. Hence the 
physical state of the drug Omeprazole and the polymers, 
Ethyl Cellulose, HPMC Eudragit S100 individually and 
the combination of drug and polymers used for 
microspheres preparation were studied by FTIR (Fourier 
transform infra-red spectroscopy) to know the drug – 
polymer compatibility. The physicochemical compatibility 
of the drugs and the polymer was obtained by FTIR studies 
(Fig No. 1 to 5).  The interpretation values of the FTIR 
were mentioned in the table No: 2.  
In FTIR spectra, C = C–N and S–C = N stretching 
link vibrations (1624.6 cm–1) and Ar–C–O–CH3 vibration 
(1202.5 cm–1) accompanied by the resonance band at 
1075.4 cm–1 were used to assess the interaction between 
the polymers and omeprazole in the solid state. The band 
positioned at 1202.5 cm–1 is related to bending vibrations 
of the methoxyl groups of Omeprazole  
Therefore, there was no alteration and no interaction was 
observed between polymer and drug in combination. All 
the characteristic peaks of Capecitabine were present in 
combination, thus indicating compatibility between drug 
and polymers and finally confirm that there was no 
chemical modification of drug has been taken place.
  
Figure 1: FTIR of pure Omeprazole 
Mohanty et al                                                Journal of Drug Delivery & Therapeutics; 2013, 3(5), 31-40   34 
© 2011, JDDT. All Rights Reserved                                                       ISSN: 2250-1177                                                      CODEN (USA): JDDTAO 
 
Figure 2: FTIR of Ethyl Cellulose 
 
Figure 3: FTIR of HPMC 
 
Figure 4: FTIR of Eudragit RS 100 
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Figure 5: FTIR of Pure Omeprazole, Ethyl Cellulose, HPMC and Eudragit RS 100 
Table 2: Comparison of FTIR peaks of drug and polymers 
S.No Formulation Wave number (cm
-1
) 
1 Omeprazole 3060.4, 3033.8, 2976.8, 2956.8, 2900.1, 2837.9, 2799.4, 2704.1, 2671.8, 2588.9, 
2558.5, 1865.2, 1747.4, 1624.6, 1575.4, 1509.3, 1463.1, 1432.7, 1403.5, 1307.6, 
1259.8,1202.5, 1156.5, 1111.7, 1075.4, 1015.7, 963.7, 855.2, 816.2 
2 Ethyl Cellulose 3469.43, 2977.96, 2881.94, 174896, 169.22, 1448.01, 139.70, 1307.151, 
1242.98, 1119.18, 1064.87, 918.95, 880.17, 705.16, 657.43, 436.77 
3 HPMC 3446.66, 2922.70, 2831.32, 1719.86, 1624.18, 1463.50, 1384.79, 1127.35, 
1068.80, 935.823, 661.83, 613.48, 566.45, 447.16 
4 Capecitabine + Ethyl 
Cellulose + HPMC 
3468.28, 2974.34, 2921.13, 2858.61, 2786.37, 2611.62, 2153.0, 1974.08, 
1826.10, 1768.89, 1731.17, 1616.51, 1486.84, 1446.08, 1380.70, 1105.72, 
923.04, 878.02, 811.36, 664.06, 575.70, 481.72, 447.04 
5 Eudragit RS100 3472.7, 2998.7, 2953.5, 2847.7, 1730.4, 1634.1, 1482.2, 1446.6, 1390.7, 1262.7, 
1192.7, 1156.4, 1062.0, 984.1, 841.7, 754.9, 489.9 
6 Omeprazole + Ethyl Cellulose 
+ HPMC + Eudragit S 100 
3451.0, 2978.3, 2925.9, 2879.2, 2618.8, 1745.5, 1636.7, 1455.8, 1383.9, 1317.7, 
1268.4, 1114.7, 1059.2, 914.6, 878.1, 805.4, 749.6 
 
DSC studies 
DSC thermograms of Omeprazole, Ethyl 
cellulose, HPMC and Eudragit RS100 along with their 
combination of drug with excipients were presented in 
Figures. 6-9. In case of Omeprazole, endothermic peak 
were observed at 157.7
0
C, which corresponds to melting 
process and the other at 423.7
0
C due to thermal 
decomposition. Thermograms of HPMC showed 
endothermic peaks at 48.7
0
C and Eudragit RS100 showed 
two endothermic peaks one at 65.6
0
C, which corresponds 
to melting process and the other at 216.9
0
C due to thermal 
decomposition Combination of drug and polymers showed 




C it may be concluded 
that the drug has not shown any interaction with different 
polymers used in preparing the different formulations. 
  
 
Figure 6: DSC Curve of Omeprazole
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Figure 7: DSC Curve of Ethyl Cellulose 
 
Figure 8: DSC Curve of HPMC 
 
Figure 9: DSC of physical mixture of Omeprazole, Ethyl Cellulose, HPMC and Eudragit RS 100 
Thus from IR spectra studies and DSC 
thermograms we can draw a conclusion that the drug 
remains in its normal form without undergoing any 
interaction with the polymers 
Micromeritic properties Omeprazole microspheres: 
Bulk and Tapped density: Bulk density and 
Tapped densities showed good packability of the 
microspheres. The values are given in table no.3 
Hausner’s ratio: Hausner‟s ratio range from 
1.129±0.0028 to 1.231±0.0040. OMP8 has lowest 
hausner‟s ratio indicating good flow. The values are given 
in table no.4 
Carr’s index: Carr‟s index range from 12.231±0.2531 to 
18.768±0.262. OMP3 has lowest Carr‟s index indicating 
good compressibility. The values are given in table no.4 
 
Angle of repose: All the formulations showed excellent 
flow ability as expressed in terms of angle of repose value 
in the range 17.36 ± 0.51 to 29.11 ± 2.39. OMP4 has 
lowest among all formulations showing excellent flow. 
The values are given in table no.4 
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Table 3: Flow properties of Omeprazole loaded microspheres 
S.No Formulation code Bulk density ± S.D Tapped density ± S.D 
1 OMP1 0.462±0.0065 0.528±0.0084 
2 OMP2 0.502±0.0077 0.581±0.0102 
3 OMP3 0.463±0.0113 0.527±0.0144 
4 OMP4 0.614±0.0124 0.714±0.0167 
5 OMP5 0.494±0.0076 0.583±0.0109 
6 OMP6 0.450±0.0061 0.538±0.0086 
7 OMP7 0.462±0.0065 0.528±0.0084 
8 OMP8 0.502±0.0077 0.581±0.0102 
 
Table 4: Derived properties of Omeprazole loaded microspheres 
S.No Formulation code Hausner’s ratio ±S.D Carr’s index± S.D Angle of repose ± S.D 
1 OMP1 1.141±0.002 12.382±0.164 23.12 ±1.042 
2 OMP2 1.159±0.002 13.732±0.195 19.17 ± 0.973 
3 OMP3 1.139±0.003 12.231±0.253 18.20 ± 0.234 
4 OMP4 1.162±0.003 13.974±0.271 17.36 ± 0.517 
5 OMP5 1.231±0.004 18.768±0.262 25.29 ± 1.544 
6 OMP6 1.168±0.003 13.684±0.272 18.19 ± 0.932 
7 OMP7 1.147±0.002 14.347±0.254 20.17 ± 0.471 
8 OMP8 1.129±0.003 13.723±0.132 19.15 ± 0.535 
 
Percentage yield 
 The percentage yield of all the formulations was 
found to be satisfactory with range of 86.92±0.029 to 
96.88±0.016. It also observed that as increase in the 
polymer concentration the percentage yield also increased. 
The values are given in table No. 5  
 
Table 5: Percentage Yield of Omeprazole loaded microspheres 
S.No Formulation code Yield (%)  ± S.D 
1 OMP1 86.92±0.029 
2 OMP2 92.16±0.043 
3 OMP3 88.08±0.029 
4 OMP4 96.35±0.016 
5 OMP5 88.32±0.016 
6 OMP6 96.88±0.016 
7 OMP7 90.93±0.016 
8 OMP8 91.95±0.016 
SEM Analysis: 
 SEM analysis was performed on the prepared Omeprazole loaded microspheres to accesses their surface 
morphological characteristics as shown in figure No.10. SEM was performed for best formulations to assess their surface. 
The polymer surface of the microspheres appeared spherical with smooth texture surface.  
The micrographs do not show any pores on microspheres. Smooth surface reveals complete removal of 
Dichloromethane from microspheres.  
 
Figure 10: SEM images of Omeprazole loaded microsphere 
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Drug content and encapsulation efficiency 
The drug content of microspheres determines the 
amount of drug entrapped in the microspheres Actual drug 
content and encapsulation efficiency of all the 
formulations are shown in table No.6. Many factors affect 
the entrapment efficiency of the drug in microspheres. E.g. 
Nature of the drug, polymer concentration, drug-polymer 
ratio and stirring speed etc. Generally low concentration of 
polymer shows low encapsulation efficiency.  
It was observed that the encapsulation efficiency increases 
with increase in polymer concentration. The encapsulation 
efficiency was good for preparation, but highest for 
formulation OMP6 
 





Actual drug loading 
±S.D 
Drug Entrapment 
Efficiency ± SD 
1 OMP1 3.508772 16.56±0.03 66.23±0.115 
2 OMP2 3.508772 16.95±0.02 67.8±0.1 
3 OMP3 4.255319 17.41±0.014 69.63±0.058 
4 OMP4 4.255319 21.51±0.014 86.03±0.057 
5 OMP5 3.846154 22.13±0.014 88.53±0.578 
6 OMP6 3.846154 19.34±0.015 77.36±0.587 
7 OMP7 3.846154 18.67±0.028 74.667±0.115 
8 OMP8 3.846154 18.02±0.025 72.1±0.1 
 
In vitro buoyancy studies: 
In vitro buoyancy studies of the prepared 
microspheres were evaluated in SGF pH 1.2. The 
formulations containing ethyl cellulose and Eudragit 
RS100 (OMP6 and OMP4) gave the floating ability in the 
range of 79.1% and 76.3%. The formulations containing 
Ethyl cellulose, Eudragit RS100 and HPMC combination 
(OMP1-OMP3, OMP5 and OMP7-OMP8) gave the 
floating ability in the range of 71.5-76.1% as shown in 
Table No.7. 
In case of formulation OMP8, the buoyancy 
percentage decreased as Compared to  other formulations 
as decrease in polymer concentration of ethyl cellulose  but 
was less as compared to Eudragit S100 containing 
formulations. Formulation OMP6 containing more 
concentration of Eudragit RS100 gave best floating ability 
of 79.1% in SGF pH 1.2 for 12 hours. This may be due to 
its low bulk density. Also, high population of small size 
microspheres and low population of big ones, allow for 
more complete and effective filling of available liquid 
surface.  
Table 7: In-vitro Buoyancy studies of Omeprazole microspheres 
 
 
In-vitro drug release: 
For all the Eight formulations there was no 
occurrence of initial burst release, but the release was 
constant in a controlled manner for a prolong period of 
time up to 12hrs. 
The above results indicated that the formulations OMP1-
OMP8 are containing different ratios of individual and 
combination of polymers. The drug release showed in 
OMP1, OMP2 and OMP6 was 94.75%, 96.92%, and 
87.26% for 12hrs. OMP3 and OMP8 showed 96.94% and 
98.83% for 8hrs. OMP4 to OMP5 showed 98.96% and 
96.83% of drug release for 9hrs.The in vitro drug release 
obtained for different formulations and comparison of drug 
release profiles for all the formulations showed in Fig 11-
19.  
 
Figure 11: Comparative Zero order plot for 
formulations OMP1-OMP2 
S.No Formulation code Percentage of Buoyancy (%) 
1 OMP1 74.8 
2 OMP2 76.1 
3 OMP3 70.9 
4 OMP4 76.3 
5 OMP5 72.8 
6 OMP6 79.1 
7 OMP7 73.6 
8 OMP8 71.5 
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Figure 2: Comparative Higuchi plot for formulations 
OMP1-OMP2 
 
Figure 13: Comparative Peppa’s plot for formulations 
OMP1-OMP2 
 
Figure 14: Comparative Zero order plot for 
formulations OMP3-OMP5 
 
Figure 15: Comparative Higuchi plot for formulations 
OMP3-OMP5 
 
Figure 16: Comparative Peppa’s plot for formulations 
OMP3-OMP5 
 
Figure 17: Comparative Zero order plot for 
formulations OMP6-OMP8 
 
Figure 18: Comparative Higuchi plot for formulations 
OMP6-OMP8 
 
Figure 19: Comparative Peppa’s plot for formulations 
OMP6-OMP8 
From the results obtained it was observed that the 
drug release from the formulations decreased with increase 
in polymer concentration. 
The formulations OMP6 and OMP1 showed 
longer duration of drug release for 12hrs in simulated 
intestinal fluid in addition to completely retarding the drug 
release in gastric medium. This is due to the combination 
of Ethyl cellulose and Eudragit S100. 
It also observed that the release was decreased 
when there was a increase in the concentration of Eudragit 
S100. OMP6 formulation showed 87.26% of drug release 
for a longer period of time up to 12hrs.  
So that OMP6 was taken as a best formulation to 
achieve a prolonged maintenance of effective 
concentrations of drug  
All the prepared formulations are having 
diffusion exponent value (n) more than 0.45 and less than 
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CONCLUSION 
Over the years, attempts have been made to control the 
time course and specificity of the drug in the body through 
a verity of drug modifications and dosage forms. The need 
of making any drug microspheres is to produce a drug 
delivery system which is safe and capable of producing 
consistent therapeutic blood levels of drug in the body for 
required period of time. It is also improves keeping and 
handling properties of the drug. In this study microspheres 
prepared by solvent evaporation method using Ethyl 
cellulose, HPMC and Eudragit S 100 showed promising 
results in delivering the drug, and the prepared 
Omeprazole microspheres exhibited prolonged intestinal 
gastric release, avoid gastric erosion side effects and thus 
improve patient compliance. 
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